Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00579579 · ClinicalTrials.gov registry record
Functional Outcomes and Quality of Life in Patients Undergoing Surgery for Rectal Cancer
A clinical trial, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- 229
- Enrollment target
NCT00579579: Completed study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00579579 is a clinical trial that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 229 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00579579 has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- 229 participants
- Enrollment target
Study Summary
The purpose of this study is to find out what happens to patients after they have surgery for rectal cancer. After being treated for rectal cancer, patients tell us that their bowel, bladder and sexual function have changed. We are trying to understand how these changes affect your quality of life. The research that we have now does not explain these changes or problems very well. The patients will be asked questions about bowel function, bladder function, sexual function, and quality of life so we can understand these changes better. This will help us take better care of our patients in the future, before and after their treatment for rectal cancer.
Interventions
- BEHAVIORAL Questionaires
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 229 participants |
| Start Date | 2006-11-28 |
| Est. Completion | 2023-02-15 |
What the finished NCT00579579 record still lists
NCT00579579 is an observational study that tracks outcomes without assigning an intervention. The registered 229 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Questionaires is the first listed.
NCT00579579 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00579579 about?
NCT00579579 is a clinical study titled "Functional Outcomes and Quality of Life in Patients Undergoing Surgery for Rectal Cancer". The purpose of this study is to find out what happens to patients after they have surgery for rectal cancer. After being treated for rectal cancer, patients tell us that their bowel, bladder and sexual function have changed. We are trying to understand how these changes affect your quality of life. ...
What is the current status of trial NCT00579579?
This trial is currently completed. The enrollment target is 229 participants. The study started on 2006-11-28. Estimated completion is 2023-02-15.
What interventions are being tested in trial NCT00579579?
The interventions under investigation include: Questionaires (BEHAVIORAL).
Who is sponsoring clinical trial NCT00579579?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02710253 · 230 participants · Phase 2
Salvage Radiation Therapy in Treating Patients With Metastatic Cancer That Has Progressed After Systemic Immunotherapy
- NCT02777879 · 230 participants
Lung Microbiome and Inflammation in Early COPD
- NCT03824483 · 230 participants · Phase 2
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)
- NCT03833622 · 230 participants · NA
Shared Decision Making to Improve Goals of Care in the ED
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI